Download Doc #72 - Contact Lens Spectrum

Contact Lens Spectrum
June 2001
Document #72
References
(p. 34) Boost Oxygen Transmission with Silicone-Hydrogel Lenses By William J.
Lahners, MD, Michael A. Ward, MMSc, FAAO, and Buddy Russell, FCLSA
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
Hull DS, Hyndiuk RA, Chin GN, Schultz RO: Clinical experience with the
therapeutic hydrophilic contact lens. Ann Ophthalmol 1975;7:555-559,
561-562.
Plotnik RD, Mannis MJ, Schwab IR: Therapeutic contact lenses. Int
Ophthalmol Clin 1991;31:35-52.
McDermott ML, Chandler JW: Therapeutic uses of contact lenses. Surv
Ophthalmol 1989;33:381-394.
Donnenfeld ED, et al: Controlled evaluation of a bandage contact lens and
a topical nonsteroidal anti-inflammatory drug in treating traumatic corneal
abrasions. Ophthalmology 1995;102:979-984.
Silbert JA: A review of therapeutic agents and contact lens wear. J Am
Optom Assoc 1996; 67:165-172.
Kaufman HE, et al: The medical uses of soft contact lenses. Trans Am
Acad Ophthalmol Otolaryngol 1971;75:361-373.
Waltman SR, Kaufman HE: Use of hydrophilic contact lenses to increase
ocular penetration of topical drugs. Invest Ophthalmol 1970;9:250-255.
Papas E: On the relationship between soft contact lens oxygen
transmissibility and induced limbal hyperaemia. Exp Eye Res
1998;67:125-131.
Baum JL: The Castroviejo Lecture. Prolonged eyelid closure is a risk to
the cornea. Cornea 1997;16:602-611.
Binder PS: The physiologic effects of extended wear soft contact lenses.
Ophthalmology 1980;87:745-749.
Sweeney DF: Corneal exhaustion syndrome with long-term wear of
contact lenses. Optom Vis Sci 1992;69:601-608.
Cohen SR, Polse KA, Brand RJ, Bonanno JA: The association between
pH level and corneal recovery from induced edema. Curr Eye Res
1995;14:349-355.
Latkovic S, Nilsson SE: The effect of high and low Dk/L soft contact
lenses on the glycocalyx layer of the corneal epithelium and on the
membrane associated receptors for lectins [see comments]. CLAO J
1997;23:185-191.
Madigan MC, Holden BA, Kwok LS: Extended wear of contact lenses
can compromise corneal epithelial adhesion. Curr Eye Res 1987;6:12571260.
15.
Thoft RA, Mobilia EF: Complications with therapeutic extended wear soft
contact lenses. Int Ophthalmol Clin 1981;21:197-208.
16.
Mondino BJ, Weissman BA, Farb MD, Pettit TH: Corneal ulcers
associated with daily-wear and extended-wear contact lenses. Am J
Ophthalmol 1986;102:58-65.
17.
Weissman BA: Risk of corneal infection and extended wear of contact
lenses. West J Med 1994; 161:595-596.
18.
Holden BA, et al: Effects of long-term extended contact lens wear on the
human cornea. Invest Ophthalmol Vis Sci 1985;26:1489-1501.
19.
Holden BA. Mertz GW: Critical oxygen levels to avoid corneal edema for
daily and extended wear contact lenses. Invest Ophthalmol Vis Sci
1984;25:1161-1167.
20.
Harvitt DM, Bonanno JA: Re-evaluation of the oxygen diffusion model for
predicting minimum contact lens Dk/t values needed to avoid corneal anoxia. Optom Vis
Sci 1999;76:712-719.
(p. 40) Topical Antihistamine Proven Safe in Single-use Lens Wear By Mark D.
Kirstein, OD, Michael B. Raizman, MD, Jason S. Rothman, MD, and Kimberly M. Farea,
OD
1. Trocme S.D., Bartley G.B., Raizman M.B. Medical therapy of ocular allergy. Mayo
Clinic Proc. 67:557-565, 1992.
2. Christensen M.T., Barry J.R., Turner F.D. Five-minute removal of soft contact lenses
prevents most absorption of a topical ophthalmic solution. CLAO. 24:227-231, 1998.
3. Chapman J.M., Cheeks L., Green K. Interactions of Benzalkonium chloride with soft
and hard contact lenses. Arch. Ophthalmol. 108:244-246, 1990.
4. Noble S., McTavish D. Levocabastine an update of its pharmacology, clinical
efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
Drugs. 50:1033-1049, 1995.
5. Smith L.M., Southwick P.C., DeRosia D.R., Abelson M.B. The effects of
levocabastine, a new highly potent and specific histamine H1-receptor antagonist, in
the ocular allergen challenge model of allergic conjunctivitis. Invest. Ophthalmol.
Visual Sci. 30:502, 1989.
6. Bahmer F.A., Ruprecht K.W. Safety and efficacy of topical levocabastine compared
with oral terfenadine. Ann. Allergy. 72:429-432, 1993.
7. Mamose T., Nobuko I., Kanai A., Watanabe Y., Shibata M. Adsorption of
Levocabastine eye drops by soft contact lenses and its effects in rabbit eyes.
CLAO.23:96-99, 1997.
8. Howarth PH. A review of the tolerability and safety of levocabastine eye drops and
nasal spray. Implications for patient management. Mediators Inflamm. 4:S26-30,
1995.